Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | POLA1 | P09884 | 1/20 | 0.42 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19071558 | 0.98 | TSHR (0.52) | TSHRLMNAALDH1A1EPHX2POLB | |
| SCHEMBL29365230 | 0.91 | TSHR (0.52) | TSHRLMNAALDH1A1EPHX2POLB | |
| SCHEMBL15593806 | 0.91 | TSHR (0.52) | TSHRLMNAALDH1A1EPHX2POLB | |
| SCHEMBL10636474 | 0.90 | TSHR (0.56) | TSHRLMNAALDH1A1EPHX2POLB | |
| SCHEMBL9105726 | 0.90 | TSHR (0.61) | TSHRLMNAALDH1A1EPHX2POLB | |
| SCHEMBL26650784 | 0.89 | TSHR (0.50) | TSHRLMNAALDH1A1EPHX2POLB | |
| SCHEMBL11949551 | 0.88 | TSHR (0.64) | TSHRLMNAALDH1A1L3MBTL1MAPT | |
| SCHEMBL9402917 | 0.87 | TSHR (0.52) | TSHRLMNAPOLBPOLA1DGKA | |
| SCHEMBL26650753 | 0.84 | POLB (0.49) | TSHRLMNAALDH1A1EPHX2POLB | |
| SCHEMBL26650816 | 0.84 | POLB (0.49) | TSHRLMNAALDH1A1EPHX2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304547-A1 | Sulfur-Containing Lipids | NANOVATION THERAPEUTICS INC. (CA) | 2025-10-02 | — | — | US | disclosed |
| WO-2023215989-A1 | SULFUR-CONTAINING LIPIDS | NANOVATION THERAPEUTICS INC. (CA) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023215989-A1 | SULFUR-CONTAINING LIPIDS | NANOVATION THERAPEUTICS INC. (CA) | 2023-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304547-A1 | Sulfur-Containing Lipids | FABP1, SLC10A1, MPST | TSHR 3430/4885LMNA 2672/4885ALDH1A1 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.